Importer of Controlled Substances; Notice of Registration

[Federal Register Volume 64, Number 27 (Wednesday, February 10, 1999)]
[Notices]
[Page 6681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-3158]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated December 12, 1998, and published in the Federal 
Register on December 11, 1998, (63 FR 68473), Celgene Corporation, 7 
Powder Horn Drive, Warren, New Jersey 07059, made application to the 
Drug Enforcement Administration to be registered as an importer of 
phenylacetone (8501) a basic class of controlled substance listed in 
Schedule II.
    The firm plans to import the phenylacetone for the bulk manufacture 
of amphetamine.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Celgene Corporation to import 
phenylacetone is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Celgene Corporation on a regular basis to ensure that the company's 
continued registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, audits of the company's records, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to Section 1008(a) of the Controlled Substances Import and Export Act 
and in accordance with Title 21, Code of Federal Regulations, Section 
1301.34, the above firm is granted registration as an importer of the 
basic class of controlled substance listed above.

    Dated: February 2, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-3158 Filed 2-9-99; 8:45 am]
BILLING CODE 4410-09-M